Come up with a name for your new list and we'll add to it:
Zafgen raised a round of funding on July 07, 2011. Investors include
Third Rock Ventures.
Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity. Beloranib, Zafgen's lead product candidate, is a novel, first-in-c…